PMID- 27135208
OWN - NLM
STAT- MEDLINE
DCOM- 20180212
LR  - 20181202
IS  - 1365-2141 (Electronic)
IS  - 0007-1048 (Linking)
VI  - 178
IP  - 2
DP  - 2017 Jul
TI  - Comments on the value International Prognostic Score (IPS), stage IV and age over 
      45 years, for the outcome of advanced Hodgkin lymphoma in chemotherapy containing 
      adriamycin. The experience of the Spanish Hodgkin Lymphoma Study Group.
PG  - 336-338
LID - 10.1111/bjh.14127 [doi]
FAU - Guisado-Vasco, Pablo
AU  - Guisado-Vasco P
AD  - Department of Internal Medicine, Hospital Quiron San Camilo, Madrid, Spain.
FAU - Montalban, Carlos
AU  - Montalban C
AD  - Department of Haematology, MD Anderson Cancer Center, Madrid, Spain.
FAU - Garcia, Juan F
AU  - Garcia JF
AD  - Department of Pathology, MD Anderson Cancer Center, Madrid, Spain.
CN  - Spanish Hodgkin Lymphoma Study Group
LA  - eng
PT  - Comment
PT  - Letter
DEP - 20160502
PL  - England
TA  - Br J Haematol
JT  - British journal of haematology
JID - 0372544
RN  - 5J49Q6B70F (Vincristine)
RN  - 5V9KLZ54CY (Vinblastine)
RN  - 80168379AG (Doxorubicin)
SB  - IM
CON - Br J Haematol. 2015 Nov;171(4):530-8. PMID: 26343802
MH  - Antineoplastic Combined Chemotherapy Protocols
MH  - *Doxorubicin
MH  - *Hodgkin Disease
MH  - Humans
MH  - Neoplasm Staging
MH  - Prognosis
MH  - Vinblastine
MH  - Vincristine
OTO - NOTNLM
OT  - Hodgkin lymphoma
OT  - clinical research
OT  - prognostic factors
EDAT- 2016/05/03 06:00
MHDA- 2018/02/13 06:00
CRDT- 2016/05/03 06:00
PHST- 2016/05/03 06:00 [pubmed]
PHST- 2018/02/13 06:00 [medline]
PHST- 2016/05/03 06:00 [entrez]
AID - 10.1111/bjh.14127 [doi]
PST - ppublish
SO  - Br J Haematol. 2017 Jul;178(2):336-338. doi: 10.1111/bjh.14127. Epub 2016 May 2.